NCT03810768 Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
| NCT ID | NCT03810768 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Technical University of Munich |
| Condition | Metabolomics |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2022-09-02 |
| Primary Completion | 2026-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2022-09-02 with a primary completion date of 2026-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this mono-center pilot trial, surgical patients who are at high risk to be admitted to intensive care will be screened and asked for participation. We are going to take blood and muscle samples at respecified time points to do metabolic, histological and molecular testing. Aim of the study is to investigate (1) changes of the blood metabolome in patients with ICUAW (intensive care unit acquired weakness) and (2) identify metabolic components who are responsible for ICUAW or can be used as marker for ICUAW.
Eligibility Criteria
Inclusion Criteria: * invasive mechanically ventilated critically ill patient with expected intensive care unit stay \> 3 days * postoperative patient * ≥ 18 years old * American Society of Anesthesiology (ASA) classification ≥ III Exclusion Criteria: * moribund patient * non-curative care (comfort care)
Contact & Investigator
Stefan J Schaller, MD
PRINCIPAL INVESTIGATOR
Technical University of Munich
Frequently Asked Questions
Who can join the NCT03810768 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Metabolomics. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03810768 currently recruiting?
Yes, NCT03810768 is actively recruiting participants. Contact the research team at stefan.schaller@meduniwien.ac.at for enrollment information.
Where is the NCT03810768 trial being conducted?
This trial is being conducted at Vienna, Austria, Munich, Germany, Berlin, Germany.
Who is sponsoring the NCT03810768 clinical trial?
NCT03810768 is sponsored by Technical University of Munich. The principal investigator is Stefan J Schaller, MD at Technical University of Munich. The trial plans to enroll 20 participants.